About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High Bleeding Risk
By
American College of Cardiology
FEATURING
Valentin Fuster
,
Dipti Itchhaporia
,
Michael Mack
,
Christine Albert
,
Julia Grapsa
February 15, 2022
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
14:31
ARCH Advanced Revascularization Symposium
Updates on Pharmacology in the Cath Lab
Feat.
J. Goetz
28:11
Top Ten Topics in Clinical Cardiology 2021
Time to Retire Aspirin?
Feat.
R. Mehran
15:40
ACC 2022 Conference Coverage
ACC 2022: Triple Therapy - When to Use and How Long
Feat.
D. Kumbhani
11:26
Houston Methodist DeBakey Heart and Vascular Center
Aspirin for the Primary Prevention of Cardiovascular Disease: What C…
Feat.
M. Miedema
21:51
Cedars Sinai
Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…
Feat.
W. Boden
07:10
American College of Cardiology
Ticagrelor with or without Aspirin in ACS after PCI (TICO)
Feat.
P. Block,
Y. Jang
12:46
AHA 2022 Conference Coverage
AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…
Feat.
F. Bakaeen
17:49
CHEST 2022 Coverage
Perioperative Management of Antithrombotic Therapy
Feat.
J. Douketis
11:07
Houston Methodist DeBakey Heart and Vascular Center
Aspirin & Primary Prevention: What Do the Guidelines Say?
Feat.
M. Gulati
14:20
ARCH Advanced Revascularization Symposium
Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines
Feat.
D. A. Cox
15:13
Cardiometabolic Health Congress (CMHC)
Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…
Feat.
D. Bhatt
13:36
Houston Methodist DeBakey Heart and Vascular Center
Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy
Feat.
J. Ferreiro
37:35
Top Ten Topics in Clinical Cardiology 2022
Top 10 Coronary Interventional Trials of 2022
Feat.
S. Sharma
08:07
Houston Methodist DeBakey Heart and Vascular Center
Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Nea…
Feat.
N. Kleiman
16:34
AHA 2022 Conference Coverage
AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…
Feat.
G. W. Stone
16:04
The 8th Annual Western New England Acute Cardiology Conference
Antiplatelet Therapy After STEMI
Feat.
R. Mehran
25:26
The Texas Heart Institute
The Use of Coronary Artery Calcium Score to Determine Benefit of Asp…
Feat.
E. Hernandez
37:51
Top Ten Topics in Clinical Cardiology 2022
Long-Term Antiplatelet/Antithrombotic Therapies in Stable CAD (Post …
Feat.
R. Mehran
12:53
Scottsdale Interventional Forum 2018
What is the Optimal DAPT Duration?
Feat.
R. Yeh
13:57
San Diego Cardiovascular Interventions 2022
Duration of Oral Antiplatelet Therapy After Complex PCI: Long-Term D…
Feat.
W. Penny
